[ORGANIZATION]
FINMA
Featured in 18 tracked stories · first seen
Situations
UBS weighs relocation amid capital rules and legal scrutiny
10 clusters · 51 sources · last updated
Latest: UBS faces capital regulation disputes and legal challenges
UBS continues to evaluate relocating its headquarters to the United States or the United Kingdom to avoid stringent Swiss capital requirements. While the Swiss government suggests relocation costs might offset regulatory
Bitcoin and Ethereum ETF flows and price volatility
64 clusters · 292 sources · last updated
Latest: Bitcoin and cryptocurrency markets face significant downturn
The cryptocurrency market transitioned from ETF-driven outflows in late 2025 to a significant rally in mid-2026, followed by renewed volatility. In August 2026, Bitcoin reclaimed levels above $70,000, supported by increa
BaFin and international regulators issue fraud warnings
2 clusters · 7 sources · last updated
Latest: Financial regulators in Germany and Switzerland issue fraud warnings
The German Federal Financial Supervisory Authority (BaFin) has issued several warnings regarding entities suspected of conducting unauthorized banking business and engaging in identity theft. Initially, BaFin flagged La
Bitcoin long-term price valuation debate
30 clusters · 89 sources · last updated
Latest: Bitcoin analysts provide varying long-term price forecasts
Financial analysts and executives continue to debate long-term Bitcoin price targets, with projections ranging from conservative floors to multi-million dollar peaks. Proponents like MicroStrategy’s Michael Saylor sugges
Switzerland Bitcoin ETF regulatory approval
2 clusters · 15 sources · last updated
Latest: Switzerland approves first spot Bitcoin ETF
The Swiss Financial Market Supervisory Authority (FINMA) has approved the country’s first spot Bitcoin exchange-traded fund (ETF) designed for retail investors. Unlike existing exchange-traded products (ETPs) that functi
Swiss pharmaceutical industry trends and growth
2 clusters · 16 sources · last updated
Latest: Roche CEO warns Europe is losing its competitive edge
The Swiss pharmaceutical sector is seeing a significant shift toward outsourcing development and manufacturing to specialized Contract Development and Manufacturing Organizations (CDMOs). Analysts indicate that the share
Also covered in
-
Finma introduces measures to reduce administrative burden for financial firms
[BUSINESS] · 2 sources ·
-
Switzerland proposes new audit rules following Credit Suisse crisis
[BUSINESS] · 2 sources ·
-
Urs Rohner fined for false statements to Finma
[BUSINESS] · 2 sources ·
-
Switzerland's FINMA approves first domestic retail Bitcoin ETF
[BUSINESS] · 3 sources ·
-
FINMA updates Swiss online identification rules to combat AI fraud
[BUSINESS] · 3 sources ·
-
Julius Baer faces FINMA sanctions over Signa loans and AML failures
[BUSINESS] · 12 sources ·
-
VQF adapts Swiss crypto compliance as Montezy GmbH joins organization
[BUSINESS] · 2 sources ·